Efficacy News and Research

RSS
Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Health Canada approves PURE Hard Surface disinfectant

Health Canada approves PURE Hard Surface disinfectant

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

St. Jude Medical announces results of Genesis neurostimulator trial on chronic migraine

St. Jude Medical announces results of Genesis neurostimulator trial on chronic migraine

Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes

Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

Telaprevir drug shows promise in curing hepatitis C infection

Telaprevir drug shows promise in curing hepatitis C infection

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Tobira commences cenicriviroc Phase IIb clinical trial for HIV infection

Tobira commences cenicriviroc Phase IIb clinical trial for HIV infection

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

22nd Century submits IND to FDA for VLN cigarettes

22nd Century submits IND to FDA for VLN cigarettes

Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis

Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis

Results of African malaria vaccine trial expected later this year

Results of African malaria vaccine trial expected later this year

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

Reduced levels of VAPB protein may play central role in causing ALS

Reduced levels of VAPB protein may play central role in causing ALS

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.